1st Quarter - Report

EMD SERONO, INC. for EMD SERONO INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2017 $610,000 Replaced
1st Quarter - Amendment Jan 22, 2018 $660,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 469: AFFORDABLE AND SAFE PRESCRIPTION DRUG IMPORTATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS RELATING TO THE RE-AUTHORIZATION OF THE PRESCRIPTION DRUG USER FEE ACT (PDUFA) IMPLEMENTATION OF PATIENT PROTECTION AND AFFORDABLE CARE ACT

LobbyistCovered position, as disclosed
MICHAEL RUGGIERO N/A
ALANNA TEMME N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 469 (115th)

Trade (domestic/foreign) TRD

S. 469: AFFORDABLE AND SAFE PRESCRIPTION DRUG IMPORTATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS RELATING TO THE IMPORTATION AMENDMENTS TO THE BUDGET RECONCILIATION BILL

LobbyistCovered position, as disclosed
MICHAEL RUGGIERO N/A
ALANNA TEMME N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 469 (115th)

Taxation/Internal Revenue Code TAX

FAMILY ACT; PROVISIONS REGARDING FERTILITY TAX CREDIT CORPORATE TAX REFORM; PROVISIONS REGARDING INTEREST DEDUCTABILITY

LobbyistCovered position, as disclosed
MICHAEL RUGGIERO N/A
ALANNA TEMME N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.